Literature DB >> 34436657

Total brachial artery reactivity and incident heart failure and heart failure subtypes: multi-ethnic study of atherosclerosis.

Daniela Charry1, Jasper Xu2, Hirofumi Tanaka3, Kevin S Heffernan4, M Ryan Richardson5, James R Churilla5.   

Abstract

Endothelial dysfunction may be a phenotypic expression of heart failure (HF). Total brachial artery reactivity (TBAR) is a non-invasive measurement of endothelial function that has been associated with increased risk of cardiovascular outcomes. Limited information is currently available on the impact of TBAR on incident HF and its subtypes. The aim of this study was to investigate whether TBAR is associated with overall incident HF, and the two HF subtypes, HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF) in a community-based study. The sample included 5499 participants (45-84 years of age) from the Multi-Ethnic Study of Atherosclerosis who were free of cardiovascular disease at baseline. Brachial artery was imaged via ultrasound after five minutes of cuff occlusion at the right forearm. TBAR was calculated as the difference between maximum and minimum brachial artery diameters following cuff release, divided by the minimum diameter multiplied by 100%. A dichotomous TBAR variable was created based on the median value (below or above 7.9%). Participants with EF ≤ 40% were considered HFrEF and those with EF ≥ 50% were considered HFpEF. Cox proportional hazards regression models were used to calculate hazard ratios (HR) and 95% confidence intervals (CI). Over a mean follow-up period of 12.5 years, incident HF was diagnosed in 250 participants: 98 classified as HFrEF, 106 as HFpEF, and 46 with unknown or borderline EF (41-49%). Crude analysis revealed that those with TBAR below the median had a significantly greater risk of HF (HR 1.46; 95% CI 1.13-1.88, p < 0.01) and HFrEF (HR 1.61; 95% CI 1.07-2.43, p < 0.05). Following adjustment for known HF risk factors (e.g., age, sex, race, blood pressure), the strength of these relationships was attenuated. Borderline significant results were revealed in those with HFpEF (HR 1.43; 95% CI 0.97-2.12, p = 0.06). Kaplan-Meier curves suggest significantly lower risks of developing HF and HFrEF in those with TBAR above the median (log-rank p ≤ 0.05 for both). When examined as a continuous variable, with a cut point of 50% for EF, every 1-standard deviation (9.7%) increase in TBAR resulted in a 19 and 29% decrease in risk of HF (p < 0.05) and HFrEF (p = 0.05), respectively. Lower TBAR values were associated with higher rates of incident HF and HFrEF, suggesting a possible role of endothelial dysfunction in HF pathogenesis. The impact of other known HF risk factors may mediate this relationship, thus further research is warranted.
© 2021. Springer Japan KK, part of Springer Nature.

Entities:  

Keywords:  Endothelial dysfunction; HFpEF; HFrEF; Heart failure

Mesh:

Year:  2021        PMID: 34436657     DOI: 10.1007/s00380-021-01933-9

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  3 in total

Review 1.  Endothelial dysfunction in heart failure.

Authors:  Johann Bauersachs; Julian D Widder
Journal:  Pharmacol Rep       Date:  2008 Jan-Feb       Impact factor: 3.024

Review 2.  Endothelial dysfunction and heart failure: A review of the existing bibliography with emphasis on flow mediated dilation.

Authors:  Sofia Giannitsi; Maria Bougiakli; Aris Bechlioulis; Katerina Naka
Journal:  JRSM Cardiovasc Dis       Date:  2019-04-11

Review 3.  Endothelial dysfunction in diabetes mellitus.

Authors:  Hadi A R Hadi; Jassim Al Suwaidi
Journal:  Vasc Health Risk Manag       Date:  2007
  3 in total
  1 in total

1.  American Heart Association EPI|Lifestyle Scientific Sessions: 2021 Meeting Highlights.

Authors:  Ruth-Alma Turkson-Ocran; Kathryn Foti; Anika L Hines; Debora Kamin Mukaz; Hyunju Kim; Samantha Martin; Anum Minhas; Faye L Norby; Oluwabunmi Ogungbe; Alexander C Razavi; Mary R Rooney; Elisabeth L P Sattler; Jewel Scott; Alvin G Thomas; Curtis Tilves; Amelia S Wallace; Frances M Wang; Mingyu Zhang; Pamela L Lutsey; Kristie J Lancaster
Journal:  J Am Heart Assoc       Date:  2022-02-18       Impact factor: 6.106

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.